DECAMETHONIUM BROMIDE Chemical Properties

Melting point:

263-267 °C(lit.)

storage temp. 

Inert atmosphere,Room Temperature

solubility 

DMF: 2 mg/ml; DMSO: 16 mg/ml; Ethanol: 33 mg/ml; PBS (pH 7.2): 5 mg/ml

form 

crystalline

color 

off-white

Water Solubility 

almost transparency

λmax

λ: 240 nm Amax: 0.04
λ: 250 nm Amax: 0.03
λ: 260 nm Amax: 0.02
λ: 500 nm Amax: 0.02

Merck 

14,2847

BRN 

3728288

Stability:

Stable. Incompatible with strong oxidizing agents.

CAS DataBase Reference

541-22-0(CAS DataBase Reference)

EPA Substance Registry System

Decamethonium dibromide (541-22-0)

Safety Information

Hazard Codes 

T

Risk Statements 

25-36/37/38

Safety Statements 

26-45

RIDADR 

UN 2811 6.1/PG 3

WGK Germany 

3

RTECS 

BP5950000

F 

3-10

HS Code 

2923.90.0100

HazardClass 

6.1(b)

PackingGroup 

III

Toxicity

LD50 oral in mouse: 190mg/kg

MSDS

• Language:English Provider:SigmaAldrich
• Language:English Provider:ALFA

DECAMETHONIUM BROMIDE Usage And Synthesis

Description

Decamethonium is a depolarizing neuromuscular blocking agent. It is a partial agonist of muscle-type nicotinic acetylcholine receptors (nAChRs). Decamethonium activates α1β1-containing adult mouse muscle-type nAChRs expressed in X. laevis oocytes with an EC₅₀ value of 40 μM using voltage clamp electrophysiology. It is also a nondepolarizing antagonist of neuronal-type nAChRs, inhibiting mouse α7-, α3β2-, α3β4-, and α4β2-containing receptors with IC₅₀ values of 7.4, 405, 28, and 59 μM, respectively. Decamethonoium is a competitive antagonist of α4β2-containing nAChRs expressed in SH-EP1 cells (IC₅₀ = 52 μM for the human receptor). It also inhibits electric eel acetylcholinesterase (AChE) and blocks electrically-evoked tibialis muscle twitches in anesthetized cats with ED₉₅ values of 35 and 70 μg/kg for cats under chloralose and ether anesthesia, respectively. Formulations containing decamethonium have been used to induce paralysis during anesthesia.

Chemical Properties

crystalline solid

Uses

antipsychotic

brand name

Syncurine (GlaxoSmithKline).

Biological Functions

Decamethonium was one of the first neuromuscular blocking agents to be synthesized. An SAR study on a series of bis-quaternary ammonium compounds with varying numbers of methylene groups separating the nitrogen atoms demonstrated that maximal neuromuscular blockade occurred with 10 to 12 unsubstituted methylene groups. Activity diminished as the number of carbons was either decreased or increased. The compound with six methylene groups, hexamethonium, is a nicotinic antagonist at autonomic ganglia (ganglionic blocking agent). All the compounds in this series that possessed neuromuscular blocking activity also caused depolarization of the postjunctional membrane.

General Description

Crystals derived from methanol and acetone.

Air & Water Reactions

Water soluble.

Health Hazard

ACUTE/CHRONIC HAZARDS: When heated to decomposition DECAMETHONIUM BROMIDE emits very toxic fumes.

Fire Hazard

Flash point data for DECAMETHONIUM BROMIDE are not available. DECAMETHONIUM BROMIDE is probably combustible.

DECAMETHONIUM BROMIDE(541-22-0)Related Product Information

• TIN (II) BROMIDE
• Cerium(III) bromide hydrate
• Magnesium bromide hexahydrate
• TITANIUM(IV) BROMIDE
• NEODYMIUM(III) BROMIDE HYDRATE
• Erythromycin
• Bicalutamide
• Mifepristone
• Perindopril erbumine
• Gabapentin
• Azithromycin
• Manganese(II) bromide tetrahydrate
• Potassium bromide
• Sodium bromide
• Cesium bromide
• Lithium bromide
• MAGNESIUM BROMIDE DIETHYL ETHERATE
• YTTRIUM BROMIDE